Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis
暂无分享,去创建一个
[1] C. Tinelli,et al. Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis , 2012, International Urogynecology Journal.
[2] S. Giordano,et al. Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study , 2012, International Urogynecology Journal.
[3] John W Stevens,et al. A note on dealing with missing standard errors in meta‐analyses of continuous outcome measures in WinBUGS , 2011, Pharmaceutical statistics.
[4] R. Autorino,et al. Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. , 2011, European urology.
[5] C. Riedl,et al. Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis , 2011, International Urogynecology Journal.
[6] M. Arianayagam,et al. Bacterial cystitis in women. , 2010, Australian family physician.
[7] Dong-Gi Lee,et al. Preventive effects of hyaluronic acid on Escherichia coli-induced urinary tract infection in rat. , 2010, Urology.
[8] Zhoujun Shen,et al. Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis. , 2010, Urology.
[9] R. Freeman,et al. An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction , 2010, Neurourology and urodynamics.
[10] D. Dressler,et al. [Anti-inflammatory action of a hyaluronic acid-chondroitin sulfate preparation in an in vitro bladder model]. , 2009, Aktuelle Urologie.
[11] J. Southgate,et al. Differentiation potential of urothelium from patients with benign bladder dysfunction , 2007, BJU international.
[12] C. Kurz,et al. Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid , 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[13] I. Hozo,et al. Estimating the mean and variance from the median, range, and the size of a sample , 2005, BMC medical research methodology.
[14] C. Constantinides,et al. Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study , 2004, BJU international.
[15] G. Sant,et al. Clinical symptoms scale for interstitial cystitis for diagnosis and for following the course of the disease , 2003, International journal of urology : official journal of the Japanese Urological Association.
[16] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[17] C. Riedl,et al. Comparative assessment of maximal bladder capacity, 0.9% NaCl versus 0.2 M Kcl, for the diagnosis of interstitial cystitis: a prospective controlled study. , 2003, The Journal of urology.
[18] Betsy Foxman,et al. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. , 2002, The American journal of medicine.
[19] A. Ronald. The etiology of urinary tract infection: traditional and emerging pathogens. , 2002, The American journal of medicine.
[20] T. Tammela,et al. Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. , 2002, Urology.
[21] S. Hultgren,et al. Dynamic interactions between host and pathogen during acute urinary tract infections. , 2001, Urology.
[22] Johnstone,et al. Glycosaminoglycan content of human bladders. a method of analysis using cold-cup biopsies. , 2000, Urologic oncology.
[23] J. Koopman,et al. Risk factors for second urinary tract infection among college women. , 2000, American journal of epidemiology.
[24] G. Reid. The Scientific Basis for Probiotic Strains ofLactobacillus , 1999, Applied and Environmental Microbiology.
[25] S. Hultgren,et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. , 1998, Science.
[26] C. Parsons. Epithelial coating techniques in the treatment of interstitial cystitis. , 1997, Urology.
[27] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.
[28] J. Avorn,et al. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. , 1994, JAMA.
[29] W. Stamm,et al. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. , 1993, The New England journal of medicine.
[30] C. Schulman,et al. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. , 1993, The Journal of urology.
[31] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[32] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.
[33] D. Laurent,et al. A randomized study , 2010 .
[34] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[35] Andrea Cipriani,et al. Imputing missing standard deviations in meta-analyses can provide accurate results. , 2006, Journal of clinical epidemiology.
[36] W. Bossart,et al. Urinary antibody response after immunisation with a vaccine against urinary tract infection , 2004, Urological Research.
[37] M. Sacks,et al. The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy. , 2002, Reviews in urology.
[38] J. Nickel,et al. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. , 1996, The Journal of urology.
[39] J. Car,et al. Recurrent urinary tract infection in women. , 1976, Nursing mirror and midwives journal.